80 FR 60400 - Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2016
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 193 (October 6, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 193 (October 6, 2015)
| Page Range | 60400-60405 | |
| FR Document | 2015-25373 |
[Federal Register Volume 80, Number 193 (Tuesday, October 6, 2015)] [Notices] [Pages 60400-60405] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-25373] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-420F] Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2016 AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Final order. ----------------------------------------------------------------------- SUMMARY: This final order establishes the initial 2016 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. DATES: Effective October 6, 2015. FOR FURTHER INFORMATION CONTACT: John R. Scherbenske, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone: (202) 598-6812. SUPPLEMENTARY INFORMATION: Legal Authority The Drug Enforcement Administration (DEA) implements and enforces titles II and III of the Comprehensive Drug Abuse Prevention and Control Act of 1970, as amended. Titles II and III are referred to as the ``Controlled Substances Act'' and the ``Controlled Substances Import and Export Act,'' respectively, and are collectively referred to as the ``Controlled Substances Act'' or the ``CSA'' for the purpose of this action. 21 [[Page 60401]] U.S.C. 801-971. The DEA publishes the implementing regulations for these statutes in title 21 of the Code of Federal Regulations (CFR), chapter II. The CSA and its implementing regulations are designed to prevent, detect, and eliminate the diversion of controlled substances and listed chemicals into the illicit market while ensuring an adequate supply is available for the legitimate medical, scientific, research, and industrial needs of the United States. Controlled substances have the potential for abuse and dependence and are controlled to protect the public health and safety. Section 306 of the Controlled Substances Act (CSA), 21 U.S.C. 826, requires the Attorney General to determine the total quantity and establish production quotas for each basic class of controlled substance in schedules I and II and for ephedrine, pseudoephedrine, and phenylpropanolamine to be manufactured each calendar year to provide for the estimated medical, scientific, research, and industrial needs of the United States, for lawful export requirements, and for the establishment and maintenance of reserve stocks. This responsibility has been delegated to the Administrator of the DEA through 28 CFR 0.100(b). Background The 2016 aggregate production quotas and assessment of annual needs represent those quantities of schedule I and II controlled substances and the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine that may be manufactured in the United States in 2016 to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. These quotas include imports of ephedrine, pseudoephedrine, and phenylpropanolamine but do not include imports of controlled substances for use in industrial processes. On July 17, 2015, a notice titled, ``Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Proposed Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2016'' was published in the Federal Register. 80 FR 42540. This notice proposed the 2016 aggregate production quotas for each basic class of controlled substance listed in schedules I and II and the 2016 assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. All interested persons were invited to comment on or object to the proposed aggregate production quotas and the proposed assessment of annual needs on or before August 17, 2015. Comments Received Twenty comments were received from four DEA-registered manufacturers within the published comment period regarding 17 different schedule I and II controlled substances. The DEA did not receive any comments regarding the proposed assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. Commenters stated that the proposed aggregate production quotas for [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen- 1-yl)methanone (THJ-2201), amphetamine (for sale), codeine (for sale), gamma hydroxybutric acid, levorphanol, marihuana, methylphenidate, N- (1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide (ADB-PINACA), N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA), N-(1-Amino-3- methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide (AB-PINACA), N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide (acetyl fentanyl), nabilone, oxymorphone (for conversion), oxymorphone (for sale), Quinolin-8-yl 1-(5-fluoropentyl)- 1H-indole-3-carboxylate (5-Flouro-PB-22), and Quinolin-8-yl 1-pentyl- 1H-indole-3-carboxylate (PB-22) were insufficient to provide for the estimated medical, scientific, research, and industrial needs of the United States, export requirements, and the establishment and maintenance of reserve stocks. Determination of 2016 Aggregate Production Quotas and Assessment of Annual Needs In determining the 2016 aggregate production quotas and assessment of annual needs, the DEA has taken into consideration the above comments along with the factors set forth at 21 CFR 1303.11 and 21 CFR 1315.11, in accordance with 21 U.S.C. 826(a), and other relevant factors, including the 2015 manufacturing quotas, current 2015 sales and inventories, anticipated 2016 export requirements, industrial use, additional applications for 2016 quotas, as well as information on research and product development requirements. Based on this information, the DEA has determined that adjustments to the proposed aggregate production quotas for codeine (for sale), hydromorphone, marihuana, methylphenidate, and N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide (acetyl fentanyl) are warranted. This final order reflects those adjustments. Regarding [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- yl)methanone (THJ-2201), amphetamine (for sale), gamma hydroxybutric acid, levorphanol, N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA), N-(1-Amino-3-methyl-1-oxobutan- 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA), N-(1- Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (AB-CHMINACA), N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide (AB-PINACA), nabilone, oxymorphone (for conversion), oxymorphone (for sale), Quinolin-8-yl 1-(5- fluoropentyl)-1H-indole-3-carboxylate (5-Flouro-PB-22), and Quinolin-8- yl 1-pentyl-1H-indole-3-carboxylate (PB-22), the DEA has determined that the proposed aggregate production quotas are sufficient to provide for the 2016 estimated medical, scientific, research, and industrial needs of the United States, export requirements, and the establishment and maintenance of reserve stocks. This final order establishes these aggregate production quotas at the same amounts as proposed. As described in the previously published notice proposing the 2016 aggregate production quotas and assessment of annual needs, the DEA has specifically considered that inventory allowances granted to individual manufacturers may not always result in the availability of sufficient quantities to maintain an adequate reserve stock pursuant to 21 U.S.C. 826(a), as intended. See 21 CFR 1303.24. This would be concerning if a natural disaster or other unforeseen event resulted in substantial disruption to the amount of controlled substances available to provide for legitimate public need. As such, the DEA has included in all established schedule II aggregate production quotas, and certain schedule I aggregate production quotas, an additional 25% of the estimated medical, scientific, and research needs as part of the amount necessary to ensure the establishment and maintenance of reserve stocks. The established aggregate production quotas will reflect these included amounts. This action will not affect the ability of [[Page 60402]] manufacturers to maintain inventory allowances as specified by regulation. The DEA expects that maintaining this reserve in certain established aggregate production quotas will mitigate adverse public effects if an unforeseen event results in the substantial disruption to the amount of controlled substances available to provide for legitimate public need, as determined by the DEA. The DEA does not anticipate utilizing the reserve in the absence of these circumstances. In accordance with 21 U.S.C. 826, 21 CFR 1303.11, and 21 CFR 1315.11, the Administrator hereby establishes the 2016 aggregate production quotas for the following schedule I and II controlled substances and the 2016 assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine, expressed in grams of anhydrous acid or base, as follows: ------------------------------------------------------------------------ Established 2016 Basic class quotas (g) ------------------------------------------------------------------------ Schedule I ------------------------------------------------------------------------ (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 25 tetramethylcyclopropyl)methanone (UR-144)........... [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- 15 yl)methanone (THJ-2201)............................. [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3- 25 tetramethylcyclopropyl)methanone (XLR11)............ 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one 25 (butylone).......................................... 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)pentan-1-one 25 (pentylone)......................................... 1-(1-Phenylcyclohexyl)pyrrolidine.................... 10 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201).... 45 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694)... 45 1-[1-(2-Thienyl)cyclohexyl]piperidine................ 15 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH- 45 200)................................................ 1-Butyl-3-(1-naphthoyl)indole (JWH-073).............. 45 1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR- 45 18 and RCS-8)....................................... 1-Hexyl-3-(1-naphthoyl)indole (JWH-019).............. 45 1-Methyl-4-phenyl-4-propionoxypiperidine............. 2 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)... 45 1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).... 45 1-Pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)... 45 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398).... 45 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122).... 45 1-Pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19, RCS-4) 45 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081).. 45 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)..... 30 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).... 30 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).... 30 2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P).. 30 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)............. 30 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2- 25 methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)...................................... 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).... 30 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2- 25 methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)...................................... 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)...... 30 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2- 15 methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)....................................... 2-(Methylamino)-1-phenylpentan-1-one (pentedrone).... 25 2,5-Dimethoxy-4-ethylamphetamine (DOET).............. 25 2,5-Dimethoxy-4-n-propylthiophenethylamine........... 25 2,5-Dimethoxyamphetamine............................. 25 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T- 30 2).................................................. 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine 30 (2C-T-4)............................................ 3,4,5-Trimethoxyamphetamine.......................... 25 3,4-Methylenedioxyamphetamine (MDA).................. 55 3,4-Methylenedioxymethamphetamine (MDMA)............. 50 3,4-Methylenedioxy-N-ethylamphetamine (MDEA)......... 40 3,4-Methylenedioxy-N-methylcathinone (methylone)..... 50 3,4-Methylenedioxypyrovalerone (MDPV)................ 35 3-Fluoro-N-methylcathinone (3-FMC)................... 25 3-Methylfentanyl..................................... 2 3-Methylthiofentanyl................................. 2 4-Bromo-2,5-dimethoxyamphetamine (DOB)............... 25 4-Bromo-2,5-dimethoxyphenethylamine (2-CB)........... 25 4-Fluoro-N-methylcathinone (4-FMC)................... 25 4-Methoxyamphetamine................................. 150 4-Methyl-2,5-dimethoxyamphetamine (DOM).............. 25 4-Methylaminorex..................................... 25 4-Methyl-N-ethylcathinone (4-MEC).................... 25 4-Methyl-N-methylcathinone (mephedrone).............. 45 4-Methyl-[alpha]-pyrrolidinopropiophenone (4-MePPP).. 25 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- 68 hydroxycyclohexyl]-phenol........................... 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]- 53 phenol (cannabicyclohexanol or CP-47,497 C8-homolog) 5-Methoxy-3,4-methylenedioxyamphetamine.............. 25 5-Methoxy-N,N-diisopropyltryptamine.................. 25 5-Methoxy-N,N-dimethyltryptamine..................... 25 Acetyl-alpha-methylfentanyl.......................... 2 [[Page 60403]] Acetyldihydrocodeine................................. 2 Acetylmethadol....................................... 2 Allylprodine......................................... 2 Alphacetylmethadol................................... 2 alpha-Ethyltryptamine................................ 25 Alphameprodine....................................... 2 Alphamethadol........................................ 2 alpha-Methylfentanyl................................. 2 alpha-Methylthiofentanyl............................. 2 alpha-Methyltryptamine (AMT)......................... 25 alpha-Pyrrolidinobutiophenone ([alpha]-PBP).......... 25 alpha-Pyrrolidinopentiophenone ([alpha]-PVP)......... 25 Aminorex............................................. 25 Benzylmorphine....................................... 2 Betacetylmethadol.................................... 2 beta-Hydroxy-3-methylfentanyl........................ 2 beta-Hydroxyfentanyl................................. 2 Betameprodine........................................ 2 Betamethadol......................................... 4 Betaprodine.......................................... 2 Bufotenine........................................... 3 Cathinone............................................ 70 Codeine methylbromide................................ 5 Codeine-N-oxide...................................... 305 Desomorphine......................................... 25 Diethyltryptamine.................................... 25 Difenoxin............................................ 11,000 Dihydromorphine...................................... 3,000,000 Dimethyltryptamine................................... 35 Dipipanone........................................... 5 Fenethylline......................................... 5 gamma-Hydroxybutyric acid............................ 70,250,000 Heroin............................................... 50 Hydromorphinol....................................... 2 Hydroxypethidine..................................... 2 Ibogaine............................................. 5 Lysergic acid diethylamide (LSD)..................... 40 Marihuana............................................ 658,000 Mescaline............................................ 25 Methaqualone......................................... 10 Methcathinone........................................ 25 Methyldesorphine..................................... 5 Methyldihydromorphine................................ 2 Morphine methylbromide............................... 5 Morphine methylsulfonate............................. 5 Morphine-N-oxide..................................... 350 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide 25 (AKB48)............................................. N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H- 50 indazole-3-carboxamide (ADB-PINACA)................. N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4- 50 fluorobenzyl)-1H-indazole-3-carboxamide (AB- FUBINACA)........................................... N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1- 15 (cyclohexylmethyl)-1H-indazole-3-carboxamide (AB- CHMINACA)........................................... N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H- 15 indazole-3-carboxamide (AB-PINACA).................. N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide 100 (acetyl fentanyl)................................... N,N-Dimethylamphetamine.............................. 25 Naphthylpyrovalerone (naphyrone)..................... 25 N-Benzylpiperazine................................... 25 N-Ethyl-1-phenylcyclohexylamine...................... 5 N-Ethylamphetamine................................... 24 N-Hydroxy-3,4-methylenedioxyamphetamine.............. 24 Noracymethadol....................................... 2 Norlevorphanol....................................... 52 Normethadone......................................... 2 Normorphine.......................................... 40 Para-fluorofentanyl.................................. 5 Parahexyl............................................ 5 Phenomorphan......................................... 2 Pholcodine........................................... 5 Psilocybin........................................... 30 Psilocyn............................................. 50 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- 50 carboxylate (5-fluoro-PB-22; 5F-PB-22).............. Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB- 50 22; QUPIC).......................................... Tetrahydrocannabinols................................ 511,250 Thiofentanyl......................................... 2 Tilidine............................................. 25 [[Page 60404]] Trimeperidine........................................ 2 ------------------------------------------------------------------------ Schedule II ------------------------------------------------------------------------ 1-Phenylcyclohexylamine.............................. 5 1-Piperidinocyclohexanecarbonitrile.................. 5 4-Anilino-N-phenethyl-4-piperidine (ANPP)............ 2,950,000 Alfentanil........................................... 17,750 Alphaprodine......................................... 3 Amobarbital.......................................... 25,125 Amphetamine (for conversion)......................... 15,000,000 Amphetamine (for sale)............................... 39,705,000 Carfentanil.......................................... 19 Cocaine.............................................. 200,000 Codeine (for conversion)............................. 50,000,000 Codeine (for sale)................................... 63,900,000 Dextropropoxyphene................................... 45 Dihydrocodeine....................................... 226,375 Dihydroetorphine..................................... 3 Diphenoxylate (for conversion)....................... 31,250 Diphenoxylate (for sale)............................. 1,337,500 Ecgonine............................................. 125,000 Ethylmorphine........................................ 3 Etorphine hydrochloride.............................. 3 Fentanyl............................................. 2,300,000 Glutethimide......................................... 3 Hydrocodone (for conversion)......................... 235,000 Hydrocodone (for sale)............................... 88,500,000 Hydromorphone........................................ 8,250,000 Isomethadone......................................... 5 Levo-alphacetylmethadol (LAAM)....................... 4 Levomethorphan....................................... 30 Levorphanol.......................................... 7,125 Lisdexamfetamine..................................... 29,750,000 Meperidine........................................... 5,450,000 Meperidine Intermediate-A............................ 6 Meperidine Intermediate-B............................ 11 Meperidine Intermediate-C............................ 6 Metazocine........................................... 19 Methadone (for sale)................................. 31,875,000 Methadone Intermediate............................... 34,375,000 Methamphetamine...................................... 2,061,375 ------------------------------------------------------------------------ [1,250,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 750,000 grams for methamphetamine mostly for conversion to a schedule III product; and 61,375 grams for methamphetamine (for sale)] ------------------------------------------------------------------------ Methylphenidate...................................... 96,750,000 Morphine (for conversion)............................ 91,250,000 Morphine (for sale).................................. 62,500,000 Nabilone............................................. 18,750 Noroxymorphone (for conversion)...................... 17,500,000 Noroxymorphone (for sale)............................ 1,475,000 Opium (powder)....................................... 112,500 Opium (tincture)..................................... 687,500 Oripavine............................................ 30,000,000 Oxycodone (for conversion)........................... 6,250,000 Oxycodone (for sale)................................. 139,150,000 Oxymorphone (for conversion)......................... 29,000,000 Oxymorphone (for sale)............................... 7,750,000 Pentobarbital........................................ 38,125,000 Phenazocine.......................................... 6 Phencyclidine........................................ 50 Phenmetrazine........................................ 3 Phenylacetone........................................ 50 Racemethorphan....................................... 3 Racemorphan.......................................... 3 Remifentanil......................................... 3,750 Secobarbital......................................... 215,003 Sufentanil........................................... 6,255 Tapentadol........................................... 25,500,000 Thebaine............................................. 125,000,000 ------------------------------------------------------------------------ [[Page 60405]] List I Chemicals ------------------------------------------------------------------------ Ephedrine (for conversion)........................... 100,000 Ephedrine (for sale)................................. 4,000,000 Phenylpropanolamine (for conversion)................. 22,400,000 Phenylpropanolamine (for sale)....................... 8,500,000 Pseudoephedrine (for conversion)..................... 7,000 Pseudoephedrine (for sale)........................... 224,500,000 ------------------------------------------------------------------------ The Administrator also establishes aggregate production quotas for all other schedule I and II controlled substances included in 21 CFR 1308.11 and 1308.12 at zero. In accordance with 21 CFR 1303.13 and 21 CFR 1315.13, upon consideration of the relevant factors, the Administrator may adjust the 2016 aggregate production quotas and assessment of annual needs as needed. Dated: September 30, 2015. Chuck Rosenberg, Acting Administrator. [FR Doc. 2015-25373 Filed 10-5-15; 8:45 am] BILLING CODE 4410-09-P
![60400 Federal Register / Vol. 80, No. 193 / Tuesday, October 6, 2015 / Notices
cannot guarantee that we will be able to OHIO mathematics, pension law and
do so. Hamilton County methodology referred to in 29 U.S.C.
1242(a)(1)(B).
CALIFORNIA William Howard Taft National Historic Site
(Boundary Increase and Additional A determination has been made as
Monterey County Documentation, 2038 Auburn Ave., required by section 10(d) of the Federal
Aeneas Sardine Packing Company Cannery, Cincinnati, 15000753 Advisory Committee Act, 5 U.S.C. App.,
300 Cannery Row, Monterey, 15000739 that the subject of the meeting falls
A request to move has been made for
within the exception to the open
COLORADO the following resource:
meeting requirement set forth in Title 5
Routt County INDIANA U.S.C. 552b(c)(9)(B), and that the public
Hayden Co-Operative Elevator Company, 198 Clay County interest requires that such meeting be
E. Lincoln Ave., Hayden, 15000740 closed to public participation.
Indiana State Highway Bridge 46–11–1316,
DISTRICT OF COLUMBIA IN 46 over Eel R., Bowling Green, Dated: September 21, 2015.
00000211 Patrick W. McDonough,
District of Columbia
In the interest of preservation a three Executive Director, Joint Board for the
Capitol Hill Historic District (Boundary day comment period has been requested Enrollment of Actuaries.
Increase II), Squares 752, 753, 777, 788 [FR Doc. 2015–25342 Filed 10–5–15; 8:45 am]
for the following resource:
bounded by 2nd, 4th & F Sts. NE.,
BILLING CODE 4830–01–P
Washington, 15000741 WISCONSIN
Davis, Colonel William Robert, House, 3020 Ozaukee County
Albemarle St. NW., Washington, 15000742
SENATOR (steam screw) Shipwreck, (Great DEPARTMENT OF JUSTICE
Young, Browne, Phelps and Springarn Lakes Shipwreck Sites of Wisconsin MPS)
Educational Campus Historic District, Address Restricted, Port Washington,
(Public School Buildings of Washington, Drug Enforcement Administration
15000738
DC MPS) 2500 Benning Rd. NE., 704, 820, [Docket No. DEA–420F]
& 850 26th St. NE., Washington, 15000743 Authority: 60.13 of 36 CFR part 60
GEORGIA Dated: September 16, 2015. Established Aggregate Production
Quotas for Schedule I and II Controlled
Stephens County Roger Reed,
Substances and Assessment of
Toccoa Downtown Historic District Acting Chief, National Register of Historic
Annual Needs for the List I Chemicals
(Boundary Increase), 118 W. Doyle St., Places/National Historic Landmarks Program.
Ephedrine, Pseudoephedrine, and
Toccoa, 15000744 [FR Doc. 2015–25375 Filed 10–5–15; 8:45 am]
Phenylpropanolamine for 2016
BILLING CODE 4312–51–P
IOWA
AGENCY: Drug Enforcement
Carroll County Administration, Department of Justice.
Manning Commercial Historic District, JOINT BOARD FOR THE ACTION: Final order.
(Iowa’s Main Street Commercial ENROLLMENT OF ACTUARIES
Architecture MPS) 217–411, 413–507, 302– SUMMARY: This final order establishes
326 Main, 717–723 3rd, 303 Center & 825 Meeting of the Advisory Committee; the initial 2016 aggregate production
5th Sts., Manning, 15000745 Meeting quotas for controlled substances in
Henry County schedules I and II of the Controlled
AGENCY: Joint Board for the Enrollment Substances Act (CSA) and the
Benjamin Chapel and Richwoods Cemetery, of Actuaries
1936 Franklin Ave., Trenton, 15000746 assessment of annual needs for the list
ACTION: Notice of Federal Advisory I chemicals ephedrine,
Boyle, Hugh and Matilda, House and Committee meeting.
Cemetery Historic District, 3225 Lexington pseudoephedrine, and
Ave., Lowell, 15000747 SUMMARY: The Executive Director of the phenylpropanolamine.
Edwards, Joseph A. and Lydia A., House, Joint Board for the Enrollment of DATES: Effective October 6, 2015.
1735 Salem Rd., Salem, 15000748 Actuaries gives notice of a closed FOR FURTHER INFORMATION CONTACT: John
Garretson, Owen A. and Emma J., House, teleconference meeting of the Advisory R. Scherbenske, Office of Diversion
1878 335th St., Salem, 15000750 Committee on Actuarial Examinations. Control, Drug Enforcement
Linn County DATES: The meeting will be held on Administration, 8701 Morrissette Drive,
Cedar Rapids 2nd Avenue SE. Automobile October 30, 2015, from 8:30 a.m. to 5:00 Springfield, VA 22152, Telephone: (202)
Row Historic District, Roughly 2nd to 3rd p.m. 598–6812.
Aves., SE., from 6th to 8th Sts., SE., Cedar FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION:
Rapids, 15000749 Patrick W. McDonough, Executive
Monroe Elementary School Historic District, Director of the Joint Board for the Legal Authority
3200 Pioneer Ave., SE., Cedar Rapids, Enrollment of Actuaries, 703–414–2173. The Drug Enforcement
15000751 SUPPLEMENTARY INFORMATION: Administration (DEA) implements and
Montgomery County Notice is hereby given that the enforces titles II and III of the
Ellis, William and Amanda J., Farmstead Advisory Committee on Actuarial Comprehensive Drug Abuse Prevention
Historic District, 1134 I Ave., Elliott, Examinations will hold a teleconference and Control Act of 1970, as amended.
tkelley on DSK3SPTVN1PROD with NOTICES
15000752 meeting on October 30, 2015, from 8:30 Titles II and III are referred to as the
a.m. to 5:00 p.m. The meeting will be ‘‘Controlled Substances Act’’ and the
NEW YORK
closed to the public. ‘‘Controlled Substances Import and
Essex County The purpose of the meeting is to Export Act,’’ respectively, and are
Helen Hill Historic District, Prescott Place, discuss topics and questions that may collectively referred to as the
Helen & Front Sts., Sheppard, Franklin & be recommended for inclusion on future ‘‘Controlled Substances Act’’ or the
Clinton Aves., Saranac Lake, 15000754 Joint Board examinations in actuarial ‘‘CSA’’ for the purpose of this action. 21
VerDate Sep<11>2014 18:31 Oct 05, 2015 Jkt 238001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1](https://thefederalregister.org/doc/80_FR_60593/page/1.svg)
methanone (THJ–2201), amphetamine
potential for abuse and dependence and controlled substances. The DEA did not (for sale), gamma hydroxybutric acid,
are controlled to protect the public receive any comments regarding the levorphanol, N-(1-Amino-3,3-dimethyl-
health and safety. proposed assessment of annual needs 1-oxobutan-2-yl)-1-pentyl-1H-indazole-
Section 306 of the Controlled for the list I chemicals ephedrine, 3-carboxamide (ADB–PINACA), N-(1-
Substances Act (CSA), 21 U.S.C. 826, pseudoephedrine, and Amino-3-methyl-1-oxobutan-2-yl)-1-(4-
requires the Attorney General to phenylpropanolamine. Commenters fluorobenzyl)-1H-indazole-3-
determine the total quantity and stated that the proposed aggregate carboxamide (AB–FUBINACA), N-(1-
establish production quotas for each production quotas for [1-(5- Amino-3-methyl-1-oxobutan-2-yl)-1-
basic class of controlled substance in fluoropentyl)-1H-indazol-3- (cyclohexylmethyl)-1H-indazole-3-
schedules I and II and for ephedrine, yl](naphthalen-1-yl)methanone (THJ– carboxamide (AB–CHMINACA), N-(1-
pseudoephedrine, and 2201), amphetamine (for sale), codeine Amino-3-methyl-1-oxobutan-2-yl)-1-
phenylpropanolamine to be (for sale), gamma hydroxybutric acid, pentyl-1H-indazole-3-carboxamide (AB–
manufactured each calendar year to levorphanol, marihuana, PINACA), nabilone, oxymorphone (for
provide for the estimated medical, methylphenidate, N-(1-Amino-3,3- conversion), oxymorphone (for sale),
scientific, research, and industrial needs dimethyl-1-oxobutan-2-yl)-1-pentyl-1H- Quinolin-8-yl 1-(5-fluoropentyl)-1H-
of the United States, for lawful export indazole-3-carboxamide (ADB– indole-3-carboxylate (5-Flouro-PB–22),
requirements, and for the establishment PINACA), N-(1-Amino-3-methyl-1- and Quinolin-8-yl 1-pentyl-1H-indole-3-
and maintenance of reserve stocks. This oxobutan-2-yl)-1-(4-fluorobenzyl)-1H- carboxylate (PB–22), the DEA has
responsibility has been delegated to the indazole-3-carboxamide (AB– determined that the proposed aggregate
Administrator of the DEA through 28 FUBINACA), N-(1-Amino-3-methyl-1- production quotas are sufficient to
CFR 0.100(b). oxobutan-2-yl)-1-(cyclohexylmethyl)- provide for the 2016 estimated medical,
1H-indazole-3-carboxamide (AB– scientific, research, and industrial needs
Background CHMINACA), N-(1-Amino-3-methyl-1- of the United States, export
The 2016 aggregate production quotas oxobutan-2-yl)-1-pentyl-1H-indazole-3- requirements, and the establishment
and assessment of annual needs carboxamide (AB–PINACA), N-(1- and maintenance of reserve stocks. This
represent those quantities of schedule I phenethylpiperidin-4-yl)-N- final order establishes these aggregate
and II controlled substances and the list phenylacetamide (acetyl fentanyl), production quotas at the same amounts
I chemicals ephedrine, nabilone, oxymorphone (for as proposed.
pseudoephedrine, and conversion), oxymorphone (for sale), As described in the previously
phenylpropanolamine that may be Quinolin-8-yl 1-(5-fluoropentyl)-1H- published notice proposing the 2016
manufactured in the United States in indole-3-carboxylate (5-Flouro-PB–22), aggregate production quotas and
2016 to provide for the estimated and Quinolin-8-yl 1-pentyl-1H-indole-3- assessment of annual needs, the DEA
medical, scientific, research, and carboxylate (PB–22) were insufficient to has specifically considered that
industrial needs of the United States, provide for the estimated medical, inventory allowances granted to
lawful export requirements, and the scientific, research, and industrial needs individual manufacturers may not
establishment and maintenance of of the United States, export always result in the availability of
reserve stocks. These quotas include requirements, and the establishment sufficient quantities to maintain an
imports of ephedrine, pseudoephedrine, and maintenance of reserve stocks. adequate reserve stock pursuant to 21
and phenylpropanolamine but do not U.S.C. 826(a), as intended. See 21 CFR
include imports of controlled Determination of 2016 Aggregate
1303.24. This would be concerning if a
substances for use in industrial Production Quotas and Assessment of natural disaster or other unforeseen
processes. Annual Needs event resulted in substantial disruption
On July 17, 2015, a notice titled, In determining the 2016 aggregate to the amount of controlled substances
‘‘Proposed Aggregate Production Quotas production quotas and assessment of available to provide for legitimate
for Schedule I and II Controlled annual needs, the DEA has taken into public need. As such, the DEA has
Substances and Proposed Assessment of consideration the above comments included in all established schedule II
Annual Needs for the List I Chemicals along with the factors set forth at 21 aggregate production quotas, and certain
Ephedrine, Pseudoephedrine, and CFR 1303.11 and 21 CFR 1315.11, in schedule I aggregate production quotas,
Phenylpropanolamine for 2016’’ was accordance with 21 U.S.C. 826(a), and an additional 25% of the estimated
tkelley on DSK3SPTVN1PROD with NOTICES
published in the Federal Register. 80 FR other relevant factors, including the medical, scientific, and research needs
42540. This notice proposed the 2016 2015 manufacturing quotas, current as part of the amount necessary to
aggregate production quotas for each 2015 sales and inventories, anticipated ensure the establishment and
basic class of controlled substance listed 2016 export requirements, industrial maintenance of reserve stocks. The
in schedules I and II and the 2016 use, additional applications for 2016 established aggregate production quotas
assessment of annual needs for the list quotas, as well as information on will reflect these included amounts.
I chemicals ephedrine, research and product development This action will not affect the ability of
VerDate Sep<11>2014 18:31 Oct 05, 2015 Jkt 238001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1](https://thefederalregister.org/doc/80_FR_60593/page/2.svg)
methanone (THJ–2201) ............................................................................... 15
[1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (XLR11) ............................................................... 25
1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone) ................................................................................................. 25
1-(1,3-Benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone) ............................................................................................. 25
1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................................. 10
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201) ...................................................................................................................... 45
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) ..................................................................................................................... 45
1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................................. 15
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH–200) ........................................................................................................ 45
1-Butyl-3-(1-naphthoyl)indole (JWH–073) ..................................................................................................................................... 45
1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR–18 and RCS–8) ................................................................................... 45
1-Hexyl-3-(1-naphthoyl)indole (JWH–019) .................................................................................................................................... 45
1-Methyl-4-phenyl-4-propionoxypiperidine ..................................................................................................................................... 2
1-Pentyl-3-(1-naphthoyl)indole (JWH–018 and AM678) ............................................................................................................... 45
1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH–203) ..................................................................................................................... 45
1-Pentyl-3-(2-methoxyphenylacetyl)indole (JWH–250) ................................................................................................................. 45
1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH–398) ..................................................................................................................... 45
1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH–122) .................................................................................................................... 45
1-Pentyl-3-[(4-methoxy)-benzoyl]indole (SR–19, RCS–4) ............................................................................................................. 45
1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH–081) ................................................................................................................ 45
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C–E) .................................................................................................................... 30
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C–D) ................................................................................................................. 30
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C–N) ................................................................................................................... 30
2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C–P) ............................................................................................................... 30
2-(2,5-Dimethoxyphenyl)ethanamine (2C–H) ................................................................................................................................ 30
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B–NBOMe; 2C–B–NBOMe; 25B; Cimbi-36) ................ 25
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C–C) .................................................................................................................. 30
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C–NBOMe; 2C–C–NBOMe; 25C; Cimbi-82) ............... 25
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C–I) ....................................................................................................................... 30
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I–NBOMe; 2C–I–NBOMe; 25I; Cimbi-5) .......................... 15
2-(Methylamino)-1-phenylpentan-1-one (pentedrone) ................................................................................................................... 25
2,5-Dimethoxy-4-ethylamphetamine (DOET) ................................................................................................................................ 25
2,5-Dimethoxy-4-n-propylthiophenethylamine ............................................................................................................................... 25
2,5-Dimethoxyamphetamine .......................................................................................................................................................... 25
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C–T–2) ......................................................................................................... 30
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C–T–4) .................................................................................................. 30
3,4,5-Trimethoxyamphetamine ...................................................................................................................................................... 25
3,4-Methylenedioxyamphetamine (MDA) ...................................................................................................................................... 55
3,4-Methylenedioxymethamphetamine (MDMA) ........................................................................................................................... 50
3,4-Methylenedioxy-N-ethylamphetamine (MDEA) ....................................................................................................................... 40
3,4-Methylenedioxy-N-methylcathinone (methylone) .................................................................................................................... 50
3,4-Methylenedioxypyrovalerone (MDPV) ..................................................................................................................................... 35
3-Fluoro-N-methylcathinone (3–FMC) ........................................................................................................................................... 25
3-Methylfentanyl ............................................................................................................................................................................. 2
3-Methylthiofentanyl ....................................................................................................................................................................... 2
4-Bromo-2,5-dimethoxyamphetamine (DOB) ................................................................................................................................ 25
4-Bromo-2,5-dimethoxyphenethylamine (2–CB) ........................................................................................................................... 25
4-Fluoro-N-methylcathinone (4–FMC) ........................................................................................................................................... 25
4-Methoxyamphetamine ................................................................................................................................................................ 150
4-Methyl-2,5-dimethoxyamphetamine (DOM) ................................................................................................................................ 25
4-Methylaminorex .......................................................................................................................................................................... 25
4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................................. 25
4-Methyl-N-methylcathinone (mephedrone) .................................................................................................................................. 45
tkelley on DSK3SPTVN1PROD with NOTICES
4-Methyl-a-pyrrolidinopropiophenone (4-MePPP) ......................................................................................................................... 25
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol ................................................................................................... 68
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP–47,497 C8-homolog) .................... 53
5-Methoxy-3,4-methylenedioxyamphetamine ................................................................................................................................ 25
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................................ 25
5-Methoxy-N,N-dimethyltryptamine ............................................................................................................................................... 25
Acetyl-alpha-methylfentanyl ........................................................................................................................................................... 2
VerDate Sep<11>2014 18:31 Oct 05, 2015 Jkt 238001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1](https://thefederalregister.org/doc/80_FR_60593/page/3.svg)
![60404 Federal Register / Vol. 80, No. 193 / Tuesday, October 6, 2015 / Notices
Established 2016
Basic class quotas (g)
Trimeperidine ................................................................................................................................................................................. 2
Schedule II
1-Phenylcyclohexylamine .............................................................................................................................................................. 5
1-Piperidinocyclohexanecarbonitrile .............................................................................................................................................. 5
4-Anilino-N-phenethyl-4-piperidine (ANPP) ................................................................................................................................... 2,950,000
Alfentanil ........................................................................................................................................................................................ 17,750
Alphaprodine .................................................................................................................................................................................. 3
Amobarbital .................................................................................................................................................................................... 25,125
Amphetamine (for conversion) ...................................................................................................................................................... 15,000,000
Amphetamine (for sale) ................................................................................................................................................................. 39,705,000
Carfentanil ...................................................................................................................................................................................... 19
Cocaine .......................................................................................................................................................................................... 200,000
Codeine (for conversion) ............................................................................................................................................................... 50,000,000
Codeine (for sale) .......................................................................................................................................................................... 63,900,000
Dextropropoxyphene ...................................................................................................................................................................... 45
Dihydrocodeine .............................................................................................................................................................................. 226,375
Dihydroetorphine ............................................................................................................................................................................ 3
Diphenoxylate (for conversion) ...................................................................................................................................................... 31,250
Diphenoxylate (for sale) ................................................................................................................................................................. 1,337,500
Ecgonine ........................................................................................................................................................................................ 125,000
Ethylmorphine ................................................................................................................................................................................ 3
Etorphine hydrochloride ................................................................................................................................................................. 3
Fentanyl ......................................................................................................................................................................................... 2,300,000
Glutethimide ................................................................................................................................................................................... 3
Hydrocodone (for conversion) ....................................................................................................................................................... 235,000
Hydrocodone (for sale) .................................................................................................................................................................. 88,500,000
Hydromorphone ............................................................................................................................................................................. 8,250,000
Isomethadone ................................................................................................................................................................................ 5
Levo-alphacetylmethadol (LAAM) .................................................................................................................................................. 4
Levomethorphan ............................................................................................................................................................................ 30
Levorphanol ................................................................................................................................................................................... 7,125
Lisdexamfetamine .......................................................................................................................................................................... 29,750,000
Meperidine ..................................................................................................................................................................................... 5,450,000
Meperidine Intermediate-A ............................................................................................................................................................ 6
Meperidine Intermediate-B ............................................................................................................................................................ 11
Meperidine Intermediate-C ............................................................................................................................................................ 6
Metazocine ..................................................................................................................................................................................... 19
Methadone (for sale) ..................................................................................................................................................................... 31,875,000
Methadone Intermediate ................................................................................................................................................................ 34,375,000
Methamphetamine ......................................................................................................................................................................... 2,061,375
[1,250,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 750,000 grams for methamphetamine mostly for
conversion to a schedule III product; and 61,375 grams for methamphetamine (for sale)]
Methylphenidate ............................................................................................................................................................................. 96,750,000
Morphine (for conversion) .............................................................................................................................................................. 91,250,000
Morphine (for sale) ........................................................................................................................................................................ 62,500,000
Nabilone ......................................................................................................................................................................................... 18,750
Noroxymorphone (for conversion) ................................................................................................................................................. 17,500,000
Noroxymorphone (for sale) ............................................................................................................................................................ 1,475,000
Opium (powder) ............................................................................................................................................................................. 112,500
Opium (tincture) ............................................................................................................................................................................. 687,500
Oripavine ........................................................................................................................................................................................ 30,000,000
Oxycodone (for conversion) .......................................................................................................................................................... 6,250,000
Oxycodone (for sale) ..................................................................................................................................................................... 139,150,000
Oxymorphone (for conversion) ...................................................................................................................................................... 29,000,000
Oxymorphone (for sale) ................................................................................................................................................................. 7,750,000
Pentobarbital .................................................................................................................................................................................. 38,125,000
Phenazocine .................................................................................................................................................................................. 6
Phencyclidine ................................................................................................................................................................................. 50
Phenmetrazine ............................................................................................................................................................................... 3
Phenylacetone ............................................................................................................................................................................... 50
Racemethorphan ........................................................................................................................................................................... 3
tkelley on DSK3SPTVN1PROD with NOTICES
Racemorphan ................................................................................................................................................................................ 3
Remifentanil ................................................................................................................................................................................... 3,750
Secobarbital ................................................................................................................................................................................... 215,003
Sufentanil ....................................................................................................................................................................................... 6,255
Tapentadol ..................................................................................................................................................................................... 25,500,000
Thebaine ........................................................................................................................................................................................ 125,000,000
VerDate Sep<11>2014 18:31 Oct 05, 2015 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1](https://thefederalregister.org/doc/80_FR_60593/page/5.svg)
![Federal Register / Vol. 80, No. 193 / Tuesday, October 6, 2015 / Notices 60405
Established 2016
Basic class quotas (g)
List I Chemicals
Ephedrine (for conversion) ............................................................................................................................................................ 100,000
Ephedrine (for sale) ....................................................................................................................................................................... 4,000,000
Phenylpropanolamine (for conversion) .......................................................................................................................................... 22,400,000
Phenylpropanolamine (for sale) ..................................................................................................................................................... 8,500,000
Pseudoephedrine (for conversion) ................................................................................................................................................ 7,000
Pseudoephedrine (for sale) ........................................................................................................................................................... 224,500,000
The Administrator also establishes DEPARTMENT OF JUSTICE To submit Send them to:
aggregate production quotas for all other comments:
schedule I and II controlled substances Notice of Lodging of Proposed
included in 21 CFR 1308.11 and Consent Decree Under the Clean Air By mail ......... Assistant Attorney General,
Act U.S. DOJ—ENRD, P.O.
1308.12 at zero. In accordance with 21 Box 7611, Washington,
CFR 1303.13 and 21 CFR 1315.13, upon D.C. 20044–7611.
consideration of the relevant factors, the On September 29, 2015, the
Administrator may adjust the 2016 Department of Justice lodged a proposed
During the public comment period,
consent decree with the United States
aggregate production quotas and the proposed consent decree may be
District Court for the Eastern District of
assessment of annual needs as needed. examined and downloaded at this
Michigan in the lawsuit entitled United
Dated: September 30, 2015.
Justice Department Web site: http://
States v. Guardian Industries Corp.,
www.justice.gov/enrd/consent-decrees.
Chuck Rosenberg, Civil Action No. 2:15-cv-13426.
We will provide a paper copy of the
Acting Administrator. The United States filed this lawsuit proposed consent decree upon written
[FR Doc. 2015–25373 Filed 10–5–15; 8:45 am] under the Clean Air Act. The complaint request and payment of reproduction
BILLING CODE 4410–09–P seeks injunctive relief and civil costs. Please mail your request and
penalties for violations of the Clean Air payment to:
Act’s Prevention of Significant Consent Decree Library, U.S. DOJ—
DEPARTMENT OF JUSTICE Deterioration requirements at eight float ENRD, P.O. Box 7611, Washington, DC
glass manufacturing furnaces owned 20044–7611.
Foreign Claims Settlement and operated by the defendant, Please enclose a check or money order
Commission Guardian Industries Corp., in Kingsburg, for $24.25 (25 cents per page
California; DeWitt, Iowa; Carleton, reproduction cost) payable to the United
[F.C.S.C. Meeting and Hearing Notice No. Michigan; Geneva, New York; Floreffe, States Treasury. For a paper copy
09–15] Pennsylvania; Richburg, South Carolina; without the exhibits and signature
and Corsicana, Texas. The consent pages, the cost is $19.50.
Sunshine Act Meeting decree requires the defendant to
Maureen M. Katz,
perform injunctive relief, which
Assistant Section Chief, Environmental
The Foreign Claims Settlement includes complying with emission
Enforcement Section, Environment and
Commission, pursuant to its regulations limitations that are comprised of Natural Resources Division.
(45 CFR 503.25) and the Government in numerical or work practice standards
[FR Doc. 2015–25339 Filed 10–5–15; 8:45 am]
the Sunshine Act (5 U.S.C. 552b), that together apply continuously at all
BILLING CODE 4410–15–P
hereby gives notice in regard to the times. The defendant will also pay a
scheduling of open meetings as follows: $312,000 civil penalty and perform a
$150,000 wood burning appliance
Thursday, October 15, 2015: 10 a.m.— replacement mitigation project in the DEPARTMENT OF LABOR
Issuance of Proposed Decisions in San Joaquin Valley area in California.
claims against Libya. Employee Benefits Security
The publication of this notice opens Administration
Status: Open a period for public comment on the
All meetings are held at the Foreign proposed consent decree. Comments 179th Meeting of the Advisory Council
Claims Settlement Commission, 600 E should be addressed to the Assistant on Employee Welfare and Pension
Street NW., Washington, DC. Requests Attorney General, Environment and Benefit Plans; Notice of Meeting
for information, or advance notices of Natural Resources Division, and should
Pursuant to the authority contained in
intention to observe an open meeting, refer to United States v. Guardian
Section 512 of the Employee Retirement
may be directed to: Patricia M. Hall, Industries Corp., D.J. Ref. No. 90–5–2–
Income Security Act of 1974 (ERISA), 29
Foreign Claims Settlement Commission, 1–11128. All comments must be
U.S.C. 1142, the 179th open meeting of
600 E Street NW., Suite 6002, submitted no later than thirty (30) days
the Advisory Council on Employee
Washington, DC 20579. Telephone: after the publication date of this notice.
Welfare and Pension Benefit Plans (also
Comments may be submitted either by
tkelley on DSK3SPTVN1PROD with NOTICES
(202) 616–6975. known as the ERISA Advisory Council)
email or by mail:
will be held on November 3–4, 2015.
Brian M. Simkin,
The meeting will take place in C5320
Chief Counsel. To submit
comments: Send them to: Room 6, U.S. Department of Labor, 200
[FR Doc. 2015–25500 Filed 10–2–15; 4:15 pm] Constitution Avenue NW., Washington,
BILLING CODE 4410–BA–P By email ....... pubcomment-ees.enrd@ DC 20210 on November 3, from 1 p.m.
usdoj.gov. to approximately 5:00 p.m. On
VerDate Sep<11>2014 18:31 Oct 05, 2015 Jkt 238001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1](https://thefederalregister.org/doc/80_FR_60593/page/6.svg)
Document Created: 2015-12-15 08:51:14
Document Modified: 2015-12-15 08:51:14
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Final order. | |
| Dates | Effective October 6, 2015. | |
| Contact | John R. Scherbenske, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone: (202) 598-6812. | |
| FR Citation | 80 FR 60400 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR